Abstract
Neutron stimulated emission computed tomography (NSECT) is being developed as a new medical-imaging technique to quantify spatial distributions of elements in a sample through inelastic scattering of fast neutrons and detection of the resulting gamma rays. It has the potential to diagnose several disorders in the human body that are characterized by changes in element concentration in the diseased tissue. NSECT is sensitive to several naturally occurring elements in the human body that demonstrate concentration changes in the presence of diseases. NSECT, therefore, has the potential to noninvasively diagnose such disorders with radiation dose that is comparable to other ionizing imaging modalities. This chapter discusses the development and progress of NSECT and presents an overview of the current status of the imaging technique.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
J. Anderson, S.B. Osborn, R.W. Tomlinson, D. Newton, J. Rundo, L. Salmon, and J.W. Smith, Neutron-Activation Analysis in Man in Vivo. a New Technique in Medical Investigation, Lancet 2, 1201–1205, (Dec 5 1964).
M.J. Chamberlain, J.H. Fremlin, D.K. Peters, and H. Philip, Total body sodium by whole body neutron activation in the living subject: further evidence for non-exchangeable sodium pool, Br. Med. J. 2, 583–585 (Jun 8, 1968).
M.J. Chamberlain, J.H. Fremlin, D.K. Peters, and H. Philip, Total body calcium by whole body neutron activation: new technique for study of bone disease, Br. Med. J. 2, 581–3, Jun 8 1968.
M.J. Chamberlain, J.H. Fremlin, D.K. Peters, and H. Philip, Measurement of whole body calcium and sodium by neutron activation analysis in the living subject, Strahlentherapie [Sonderb], 67, 178–85, 1968.
M.J. Chamberlain, Whole-body neutron activation analysis, Proc. R. Soc. Med. 62, 370–3 (Apr 1969).
M.J. Chamberlain, J.H. Fremlin, I. Holloway, and D.K. Peters, Use of the cyclotron for whole body neutron activation analysis: theoretical and practical considerations, Int. J. Appl. Radiat. Isot. 21, 725–34 (Dec 1970).
M.J. Chamberlain, J.H. Fremlin, D.K. Peters, and H. Philip, Applications of the whole-body counter in total-body neutron activation analysis, Br. J. Radiol. 43, 287–8 (Apr 1970).
M.J. Chamberlain and J.H. Fremlin, Measurement of whole-body nitrogen by pulsed neutron activation analysis, Strahlentherapie [Sonderb] 72, 88–93 (1972).
S.H. Cohn and C.S. Dombrowski, Measurement of total-body calcium, sodium, chlorine, nitrogen, and phosphorus in man by in vivo neutron activation analysis, J. Nucl. Med. 12, 499–505 (Jul 1971).
D. Vartsky, K.J. Ellis, and S.H. Cohn, In vivo measurement of body nitrogen by analysis of prompt gammas from neutron capture, J. Nucl. Med. 20, 1158–1155 (Nov 1979).
C.L. Hollas, L.E. Ussery, K.B. Butterfield, and R.E. Morgado, A method for in vivo determination of carbon and oxygen using prompt gamma radiations induced by 14.7-MeV neutrons, Basic Life Sci. 55, 395–400 (1990).
H.C. Biggin, N.S. Chen, K.V. Ettinger, J.H. Fremlin, W.D. Morgan, R. Nowotny, M.J. Chamberlain, and T.C. Harvey, Cadmium by in vivo neutron activation analysis, in J. Radioanal. Chem, v. 19, no. 2, pp. 207–214; International colloquium on activation analysis of very low amounts of elements; 2 Oct 1972; Saclay, France United Kingdom (1974).
M.L. Arnold, F.E. McNeill, I.M. Stronach, A. Pejovic-Milic, D.R. Chettle, and A. Waker, An accelerator based system for in vivo neutron activation analysis measurements of manganese in human hand bones, Med. Phys. 29, 2718–24 (Nov 2002).
A. Garg, V. Singh, et al., An elemental correlation study in cancerous and normal breast tissue with successive clinical stages by neutron activation analysis, Biol. Trace Element Res. 46, 185–202 (1994).
A. Danielsen and E. Steinnes, A study of some selected trace elements in normal and cancerous tissue by neutron activation analysis, J. Nucl. Med. 11, 260–4 (Jun 1970).
K.H. Ng, D.A. Bradley, and L.M. Looi, Elevated trace element concentrations in malignant breast tissues, Br. J. Radiol. 70, 375–82 (Apr 1997).
K.H. Ng, D.A. Bradley, L.M. Looi, C.S. Mahmood, and A.K. Wood, Differentiation of elemental composition of normal and malignant breast tissue by instrumental neutron activation analysis, Appl. Radiat. Isot. 44, 511–6 (Mar 1993).
K.J. Ellis, Human body composition: in vivo methods, Physiol. Rev. 80, 649–80 (Apr 2000).
J.F. Sutcliffe, A review of in vivo experimental methods to determine the composition of the human body, Phys. Med. Biol. 41, 791–833 (May 1996).
E. Witkowska, K. Szczepaniak, and M. Biziuk, Some applications of neutron activation analysis: A review, J. Radioanal. Nucl. Chem. 265, 141–150 (2005).
S. Mattsson and B.J. Thomas, Development of methods for body composition studies, Phys. Med. Biol. 51, R203–28 (Jul 7 2006).
K. Kyere, B. Oldroyd, C.B. Oxby, L. Burkinshaw, R.E. Ellis, and G.L. Hill, The feasibility of measuring total body carbon by counting neutron inelastic scatter gamma rays, Phys. Med. Biol. 27, 805–17 (Jun 1982).
J.J. Kehayias, S.B. Heymsfield, A.F. LoMonte, J. Wang, and R.N. Pierson, Jr., In vivo determination of body fat by measuring total body carbon, Am. J. Clin. Nutr. 53, 1339–44 (Jun 1991).
J.J. Kehayias, Aging and body composition: possibilities for future studies, J. Nutr. 123, 454–8 (Feb 1993).
J.J. Kehayias, H. Zhuang, V. Hughes, and L. Dowling, Assessment of body fat and lean in the elderly by measuring body carbon and oxygen: validation against hydrodensitometry, Appl. Radiat. Isot. 49, 723–5 (May-Jun 1998).
J.J. Kehayias, S. Valtuena, A.B. Waitekus, C.A. Sheahan, and M. O'Neill, In vivo elemental partition analysis using fast neutrons. A tool for testing the efficacy of new clinical interventions, Ann. N Y. Acad. Sci. 904, 140–7 (May 2000).
L. Wielopolski, R.C. Ancona, R.T. Mossey, A.N. Vaswani, and S.H. Cohn, Nuclear resonance scattering measurement of human iron stores, Med. Phys. 12, 401–4 (Jul-Aug 1985).
L. Wielopolski and E.C. Zaino, Noninvasive in-vivo measurement of hepatic and cardiac iron, J. Nucl. Med. 33, 1278–82 (Jul 1992).
L. Wielopolski, Feasibility of measuring iron in vivo using fast 14 MeV neutrons, Cooley’s Anemia Foundation Inc. BNL-7980–2005 (2005).
C.E. Floyd, C.R. Howell, B.P. Harrawood, A.S. Crowell, A.J. Kapadia, R. Macri, J.Q. Xia, R. Pedroni, J. Bowsher, M.R. Kiser, G.D. Tourassi, W. Tornow, and R. Walter, Neutron Stimulated Emission Computed Tomography of Stable Isotopes, in SPIE Symposium on Medical Imaging, San Diego, CA, pp. 248–254 (2004).
C.E. Floyd, J.E. Bender, A. Sharma, A. Kapadia, J. Xia, B. Harrawood, G.D. Tourassi, J. Lo, and C.R. Howell, Introduction to Neutron Stimulated Emission Computed Tomography. Phys. Med. Biol. 50 (14), 3375–90 (2005).
A.J. Kapadia, A.C. Sharma, J.E. Bender, G.D. Tourassi, C.R. Howell, A.S. Crowell, M.R. Kiser, B.P. Harrawood, and C.E. Floyd, Neutron Stimulated Emission Computed Tomography for Diagnosis of Breast Cancer, IEEE Trans Nucl. Sci. 55, 501–509 (2008).
A.J. Kapadia, G.D. Tourassi, A.C. Sharma, A.S. Crowell, M.R. Kiser, and C.R. Howell, Experimental detection of iron overload in liver through neutron stimulated emission spectroscopy, Phys. Med. Biol. 53, 2633–2649 (2008).
C.E. Floyd, J.E. Bender, A.C. Sharma, A.J. Kapadia, J.Q. Xia, B.P. Harrawood, G.D. Tourassi, J.Y. Lo, A.S. Crowell, and C.R. Howell, Introduction to neutron stimulated emission computed tomography, Phys. Med. Biol. 51, 3375–3390 (2006).
M.N. Wernick and J.N. Aarsvold, Emission Tomography: The Fundamentals of PET and SPECT: Academic Press, San Diego (2004).
A. Kak and M. Slaney, Principles of computerized tomographic imaging vol. 33. Philadelphia: society for industrial and applied mathematics (2001).
J.E. Bender, C.E. Floyd, B.P. Harrawood, A.J. Kapadia, A.C. Sharma, and J.L. Jesneck, The effect of detector resolution for quantitative analysis of neutron stimulated emission computed tomography, in SPIE Medical Imaging, pp. 1597–1605 (2006).
L.W. Powell, Diagnosis of hemochromatosis, Semin. Gastrointest Dis. 13, 80–8 (Apr 2002).
S. Joffe, Hemochromatosis, N. Lamki, B. Coombs, U. Schmiedl, R.M. Krasny, and J. Karani, Eds., Medscape emedicine, emedicine.medscape.com/article/369012-overview, Mar 11, 2005.
L. Powell, Hemochromatosis, in D. Kasper, Fawci, AS, Longo, DL, Braunwald, E, Hauser, SL, Jameson, JL, Ed.,Harrison's Principles of Internal Medicine, 16 ed. vol. 2, McGraw Hill, New York, NY, pp. 2298–2303 (2005).
G. Brewer, Wilson Disease, in D. Kasper, Fawci, AS, Longo, DL, Braunwald, E, Hauser, SL, Jameson, JL, Ed., Harrison's Principals of Internal Medicine, 16 ed. vol. 2, NY: McGraw Hill, pp. 2313–2315 (2005).
H. Mussalo-Rauhamaa, S. Piepponen, J. Lehto, R. Kauppila, and O. Auvinen, Cu, Zn, Se and Mg concentrations in breast fat of Finnish breast cancer patients and healthy controls, Trace Elements Med. 10, 13–15 (1993).
K. Geraki, M.J. Farquharson, and D.A. Bradley, X-ray fluorescence and energy dispersive x-ray diffraction for the quantification of elemental concentrations in breast tissue, Phys. Med. Biol. 49, 99–110 (Jan 7 2004).
U. Majewska, D. Banas, J. Braziewicz, S. Gozdz, A. Kubala-Kukus, and M. Kucharzewski, Trace element concentration distributions in breast, lung and colon tissues, Phys. Med. Biol. 52, 3895–911 (Jul 7 2007).
K. Geraki, M.J. Farquharson, and D.A. Bradley, Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study, Phys. Med. Biol. 47, 2327–39 (Jul 7 2002).
S.L. Rizk and H.H. Sky-Peck, Comparison between concentrations of trace elements in normal and neoplastic human breast tissue, Cancer. Res. 44, 5390–4 (Nov 1984).
S. Rizk and H. Sky-Peck, Comparison between Concetrations of Trace Elements in Normal and Neoplastic Human Breast Tissue, Cancer. Research. 44, 5390–539 (1984).
P.M. Santoliquido, H.W. Southwick, and J.H. Olwin, Trace metal levels in cancer of the breast, Surg. Gynecol. Obstet. 142, 65–70 (Jan 1976).
M. Brys, A.D. Nawrocka, E. Miekos, C. Zydek, M. Foksinski, A. Barecki, and W.M. Krajewska, Zinc and cadmium analysis in human prostate neoplasms, Biol. Trace. Elem. Res. 59, 145–52 (Winter 1997).
A. Feustel, R. Wennrich, D. Steiniger, and P. Klauss, Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH), Urol. Res. 10, 301–3 (1982).
V. Zaichick, T.V. Sviridova, and S.V. Zaichick, Zinc in the human prostate gland: normal, hyperplastic and cancerous, Int. Urol. Nephrol. 29, 565–74 (1997).
E. Andrasi, M. Suhajda, I. Saray, L. Bezur, L. Ernyei, and A. Reffy, Concentration of elements in human brain: glioblastoma multiforme, Sci. Total. Environ. 139/140, 399–402 (Nov 1 1993).
M. Persigehl, H. Schicha, K. Kasperek, and H.J. Klein, Trace element concentration in human organs in dependence of age, Beitr. Path. 161, 209–220 (1977).
E.J. Margalioth, J.G. Schenker, and M. Chevion, Copper and zinc levels in normal and malignant tissues, Cancer 52, 868–72 (Sep 1 1983).
P. Ghadirian, P. Maisonneuve, C. Perret, G. Kennedy, P. Boyle, D. Krewski, and A. Lacroix, A case-control study of toenail selenium and cancer of the breast, colon, and prostate, Cancer. Detect. Prev. 24, 305–13 (2000).
I. Kato, A.M. Dnistrian, M. Schwartz, P. Toniolo, K. Koenig, R.E. Shore, A. Zeleniuch-Jacquotte, A. Akhmedkhanov, and E. Riboli, Iron intake, body iron stores and colorectal cancer risk in women: a nested case-control study, Int. J. Cancer. 80, 693–8 (Mar 1 1999).
R.L. Nelson, F.G. Davis, E. Sutter, L.H. Sobin, J.W. Kikendall, and P. Bowen, Body iron stores and risk of colonic neoplasia, J. Natl. Cancer. Inst. 86, 455–60 (Mar 16 1994).
K. Witkowski, A. Kozlowski, M. Pardela, J. Piecuch, and P. Walichiewicz, [Level of copper in plasma and tissue of patients with esophageal and large bowel cancer], Wiad. Lek. 46, 586–8 (Aug 1993).
K.Q. Xiao and W.J. Henderson, [Electron microscopy microanalysis and quantitative detection of trace elements in carcinoma of the colon], Zhonghua Bing Li Xue Za Zhi 21, 142–5 (Jun 1992).
W.P. Banner, J.J. DeCosse, Q.H. Tan, and M.S. Zedeck, Selective distribution of selenium in colon parallels its antitumor activity, Carcinogenesis 5, 1543–6 (Dec 1984).
G.C. Gregoriadis, N.S. Apostolidis, A.N. Romanos, and T.P. Paradellis, A comparative study of trace elements in normal and cancerous colorectal tissues, Cancer 52, 508–19 (Aug 1 1983).
Z.M. Bataineh, I.H. Bani Hani, and J.R. Al-Alami, Zinc in normal and pathological human prostate gland, Saudi. Med. J. 23, 218–20 (Feb 2002).
A. Feustel, R. Wennrich, and H. Dittrich, Investigations of trace elements in metastases and primary carcinoma of the prostate, Urol. Res. 17, 107–9 (1989).
J.O. Ogunlewe and D.N. Osegbe, Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate, Cancer 63, 1388–92 (Apr 1 1989).
I. Romics and L. Katchalova, Spectrographic determination of zinc in the tissues of adenoma and carcinoma of the prostate, Int. Urol. Nephrol. 15, 171–6 (1983).
M. Yaman, D. Atici, S. Bakirdere, and I. Akdeniz, Comparison of trace metal concentrations in malign and benign human prostate, J. Med. Chem. 48, 630–634 (2005).
F.K. Habib, G.L. Hammond, I.R. Lee, J.B. Dawson, M.K. Mason, P.H. Smith, S.R.Y.K. Stitch, A.G. Meade, E.P. Rack, and A.J. Blotcky, Metal-androgen interrelationships in carcinoma and hyperplasia of the human prostate, J. Endocrinol., 61 (1), 133–41 (1976).
H. Kubo, S. Hashimoto, and A. Ishibashi, Simultaneous determinations of Fe, Cu, Zn, and Br concentrations in human tissue sections, Med. Phys. 3, 204–9 (Jul-Aug 1976).
G.M. Brittenham and D.G. Badman, Noninvasive measurement of iron: report of an NIDDK workshop, Blood 101, 15–9 (Jan 1 2003).
J.M. Alustiza, J. Artetxe, A. Castiella, C. Agirre, J.I. Emparanza, P. Otazua, M. Garcia-Bengoechea, J. Barrio, F. Mujica, and J.A. Recondo, MR quantification of hepatic iron concentration, Radiology 230, 479–84 (Feb 2004).
W.F. Avrin and S. Kumar, Noninvasive liver-iron measurements with a room-temperature susceptometer, Physiol. Meas. 28, 349–61 (Apr 2007).
H.L. Bonkovsky, R.B. Rubin, E.E. Cable, A. Davidoff, T.H. Rijcken, and D.D. Stark, Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques, Radiology 212, 227–34 (Jul 1999).
G.M. Brittenham, S. Sheth, C.J. Allen, and D.E. Farrell, Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease, Semin. Hematol. 38, 37–56 (Jan 2001).
E. Cecchin, S. De Marchi, F. Querin, M.G. Marin, R. Fiorentino, and F. Tesio, Efficacy of hepatic computed tomography to detect iron overload in chronic hemodialysis, Kidney. Int. 37, 943–50 (Mar 1990).
R.W. Chapman, G. Williams, G. Bydder, R. Dick, S. Sherlock, and L. Kreel, Computed tomography for determining liver iron content in primary haemochromatosis, Br. Med. J. 280, 440–2 (Feb 16 1980).
J.L. Chezmar, R.C. Nelson, J.A. Malko, and M.E. Bernardino, Hepatic iron overload: diagnosis and quantification by noninvasive imaging, Gastrointest. Radiol. 15, 27–31 (Winter 1990).
R.M. Dixon, P. Styles, F.N. al-Refaie, G.J. Kemp, S.M. Donohue, B. Wonke, A.V. Hoffbrand, G.K. Radda, and B. Rajagopalan, Assessment of hepatic iron overload in thalassemic patients by magnetic resonance spectroscopy, Hepatology 19, 904–10 (Apr 1994).
Y. Gandon, D. Olivie, D. Guyader, C. Aube, F. Oberti, V. Sebille, and Y. Deugnier, Non-invasive assessment of hepatic iron stores by MRI., Lancet 363, 357–362 (Jan 31, 2004 2004).
D. Guyader, Y. Gandon, J.Y. Robert, J.F. Heautot, H. Jouanolle, C. Jacquelinet, M. Messner, Y. Deugnier, and P. Brissot, Magnetic resonance imaging and assessment of liver iron content in genetic hemochromatosis, J Hepatol 15, 304–8 (Jul 1992).
J.M. Howard, C.N. Ghent, L.S. Carey, P.R. Flanagan, and L.S. Valberg, Diagnostic efficacy of hepatic computed tomography in the detection of body iron overload, Gastroenterology 84, 209–15 (Feb 1983).
P. Liu, M. Henkelman, J. Joshi, P. Hardy, J. Butany, M. Iwanochko, M. Clauberg, M. Dhar, D. Mai, S. Waien, and N. Olivieri, Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a nvel murine thalassemia-cardiac iron overload model, Can. J. Cardiol. 12, 155–64 (Feb 1996).
P. Nielsen, R. Engelhardt, M. Duerken, G.E. Janka, and R. Fischer, Using SQUID biomagnetic liver susceptometry in the treatment of thalassemia and other iron loading diseases, Transfus. Sci. 23, 257–8 (Dec 2000).
P. Nielsen, R. Engelhardt, J. Dullmann, and R. Fischer, Non-invasive liver iron quantification by SQUID-biosusceptometry and serum ferritin iron as new diagnostic parameters in hereditary hemochromatosis, Blood Cells Mol. Dis. 29, 451–8 (Nov-Dec 2002).
P. Nielsen, U. Kordes, R. Fischer, R. Engelhardt, and G.E. Janka, [SQUID-biosusceptometry in iron overloaded patients with hematologic diseases], Klin Padiatr 214, 218–22 (Jul-Aug 2002).
H. Perrimond, C. Chagnon, I. Moulanier, G. Michel, H. Guidicelli, and P.J. Bernard, The value of nuclear magnetic resonance in the study of iron overload in thalassemia patients, Ann. Pediatr. (Paris) 38, 175–84 (Mar 1991).
S. Sheth, SQUID biosusceptometry in the measurement of hepatic iron, Pediatr. Radiol. 33, 373–7 (Jun 2003).
D. Vartsky, K.J. Ellis, D.M. Hull, and S.H. Cohn, Nuclear resonant scattering of gamma rays – a new technique for in vivo measurement of body iron stores, Phys. Med. Biol. 24, 689–701 (Jul 1979).
D. Vartsky, L. Wielopolski, K.J. Ellis, and S.H. Cohn, The Use of Nuclear Resonant Scattering of Gamma-Rays for Invivo Measurement of Iron, Nucl. Instrum. Meth. Phys. Res. 193, 359–364 (1982).
E. Angelucci, A. Giovagnoni, G. Valeri, E. Paci, M. Ripalti, P. Muretto, C. McLaren, G.M. Brittenham, and G. Lucarelli, Limitations of magnetic resonance imaging in measurement of hepatic iron, Blood  90, 4736–42 (Dec 15 1997).
Z.J. Wang, J.C. Haselgrove, M.B. Martin, A.M. Hubbard, S. Li, K. Loomes, J.R. Moore, H. Zhao, and A.R. Cohen, Evaluation of iron overload by single voxel MRS measurement of liver T2, J. Magn. Reson. Imaging 15, 395–400 (Apr 2002).
A.J. Kapadia, A.C. Sharma, G.D. Tourassi, J.E. Bender, A.S. Crowell, M.R. Kiser, C.R. Howell, and C.E. Floyd, Neutron Spectroscopy of Mouse Using Neutron Stimulated Emission Computed Tomography (NSECT), in IEEE Nuclear Science Symposium, Medical Imaging Conference, San Diego, CA, pp. 3546–3548 (2006).
A.C. Sharma, G.D. Tourassi, A.J. Kapadia, A.S. Crowell, M.R. Kiser, A. Hutcheson, B.P. Harrawood, C.R. Howell, and C.E. Floyd, Elemental Spectrum of a Mouse Obtained via Neutron Stimulation., in 2007 SPIE Symposium on Medical Imaging, San Diego, CA, p. 65100Â K (2007).
C.E. Floyd, A.C. Sharma, J.E. Bender, A.J. Kapadia, J.Q. Xia, B.P. Harrawood, G.D. Tourassi, J.Y. Lo, M.R. Kiser, A.S. Crowell, R.S. Pedroni, R.A. Macri, S. Tajima, and C.R. Howell, Neutron Stimulated Emission Computed Tomography: Background Corrections, Nucl. Instrum. Meth. Phys. Res. Sect. B 254, 329–336 (2007).
C.E. Floyd, A.J. Kapadia, J.E. Bender, A.C. Sharma, J.Q. Xia, B.P. Harrawood, G.D. Tourassi, J.Y. Lo, A.S. Crowell, M.R. Kiser, and C.R. Howell, Neutron Stimulated Emission Computed Tomography of a Multi-Element Phantom, Phys. Med. Biol. 53, 2313–2326 (2008).
K. Lange and R. Carson, EM reconstruction Algorithms for Emission and Transmission Tomography, Journal of Computer Assisted Tomography  8, 306–316 (1984).
A.J. Kapadia, Accuracy and Patient Dose in Neutron Stimulated Emission Computed Tomography for Diagnosis of Liver Iron Overload: Simulations in GEANT4, in Biomedical Engineering. vol. PhD, Duke University, Durham, NC (2007).
W.A. Watson, III, J. Chen, G. Heyes, E. Jastrzembski, and D. Quarrie, CODA: a scalable, distributed data acquisition system, in IEEE Transactions on Nuclear Science, Vancouver, BC, Canada, pp. 61–68 (1994).
R. Fox, C. Bolen, K. Orji, and J. Venema, NSCLSpecTcl Meeting the Needs of Preliminary Nuclear Physics Data Analysis in 11'th Annual Tcl/Tk Conference New Orleans, Louisiana (2004).
RSNA, Radiation Exposure in X-ray Examinations, in American College of Radiology (ACR) and the Radiological Society of North America (RSNA) (2007).
A.C. Sharma, B.P. Harrawood, J.E. Bender, G.D. Tourassi, and A.J. Kapadia, Neutron stimulated emission computed tomography: a Monte Carlo simulation approach, Phys. Med. Biol. 52, 6117–31 (Oct 21 2007).
J.E. Bender, A.J. Kapadia, A.C. Sharma, G.D. Tourassi, B.P. Harrawood, and C.E. Floyd, Breast cancer detection using Neutron Stimulated Emission Computed Tomography: prominent elements and dose requirements, Med. Phys. 34, 3866–3871 (2007).
A.J. Kapadia, C.E. Floyd, C.R. Howell, and B.P. Harrawood, Sampling Requirements for Neutron Stimulated Emission Computed Tomography, in RSNA, Physics (Digital Imaging, PACS) session Chicago, IL (2004).
Acknowledgment
The author would like to acknowledge and thank all the members of the Duke Advanced Imaging Laboratories (DAILabs) and Triangle Universities Nuclear Laboratory (TUNL) who have been involved in the development of NSECT, especially Georgia Tourassi, Amy Sharma, and Janelle Bender for their analytical contribution and deep involvement in NSECT; Brian Harrawood for his unparalleled computing support; Calvin Howell, Alexander Crowell, Matthew Kiser, and Robert Macri for their help and guidance with NSECT acquisition experiments; and Anton Tonchev and Anthony Hutcheson for their help with gamma detector setup and management. Finally, the author would like to express his deep gratitude to Dr. Carey Floyd, the pioneer of NSECT, in whose memory and name this research continues.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Kapadia, A.J. (2009). Neutron Stimulated Emission Computed Tomography: A New Technique for Spectroscopic Medical Imaging. In: Bilheux, H., McGreevy, R., Anderson, I. (eds) Neutron Imaging and Applications. Neutron Scattering Applications and Techniques. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-78693-3_15
Download citation
DOI: https://doi.org/10.1007/978-0-387-78693-3_15
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-78692-6
Online ISBN: 978-0-387-78693-3
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)